Pharma firm urged to share new ‘game-changer’ HIV drug

By Michael Andisile Mayalo | Published May 30, 2024

Lenacapavir, which was approved for use in the US and the EU in 2022, only needs to be injected twice a year, making it particularly suited for people normally “excluded from high-quality health care”, the open letter said.